Association of serum alpha-1 antitrypsin level with the severity of COPD
DOI:
https://doi.org/10.18203/2320-6012.ijrms20241525Keywords:
Antitrypsin level, Serum Alpha-1, Severity of COPDAbstract
Background: Alpha-1 antitrypsin deficiency (AATD) is a hereditary disorder linked to early onset COPD, notably the emphysema variety, but often goes undetected. Low serum AAT levels may impact lung function and correlate with COPD severity. The aim of the study was to detect possible associations of serum AAT level with the severity of COPD patients on the basis of post bronchodilator FEV1 in Bangabandhu Sheikh Mujib Medical University (BSMMU).
Methods: A cross-sectional study was conducted at the Department of Respiratory Medicine, BSMMU, Dhaka, from October 2022 to September 2023. Adult patients (≥18 years) of both genders diagnosed with COPD based on spirometry were included. COPD was defined per GOLD guidelines, with a post-bronchodilator FEV1/FVC ratio <70%. Severity was categorized based on post-bronchodilator FEV1% predicted. Association between serum AAT level and COPD severity was analyzed using SPSS version 26, with significance set at p <0.05.
Results: The study involved 80 COPD patients, with 1.25% showing low serum AAT levels and 98.75% normal. No significant differences in age, sex, or smoking status were observed among severity groups. Mean serum AAT levels varied across severity groups but were not statistically significant (p=0.377). Smoking was prevalent (66.3%), with common comorbidities like hypertension (26.3%), IHD (16.3%), and diabetes mellitus (15.0%). Shortness of breath (95.0%) and cough (92.5%) were common symptoms, with most patients having moderate disease severity (42.5%).
Conclusions: The study indicates a weak association between serum AAT levels and COPD severity, with only 1.25% of 80 patients exhibiting low AAT levels.
Metrics
References
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of COPD Executive Summary, 2023. Available at: https://goldcopd.org/2023-gold-report-2/. Accessed 01 March 2023.
Carrell RW, Lomas DA, Sidhar S, Foreman R. α1-Antitrypsin deficiency: a conformational disease. Chest. 1996;110(6):243S-7S.
Laurell CB, Eriksson S. The electrophoretic α; 1-globulin pattern of serum in α; 1-antitrypsin deficiency. Scand J Cli Labor Investigat. 1963;15(2):132-40.
Vidal R, Blanco I, Casas F, Jardí R, Miravitlles M, National Alpha-1 Antitrypsin Registry Committee. Guidelines for the diagnosis and management of α1-antitrypsin deficiency. Archi Bronconeumolo. 2006;42(12):645-59.
Brantly M. α 1-Antitrypsin: not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am J Respi Cell Mole Biol. 2002;27(6):652-4.
Vidal, R., Blanco, I., Casas, F., Jardí, R., Miravitlles, M. and National Alpha-1 Antitrypsin Registry Committee, 2006. Guidelines for the diagnosis and management of α1-antitrypsin deficiency. Archivos de Bronconeumología ((English Edition)), 42(12), pp.645-659.
Campos MA, Wanner A, Zhang G, Sandhaus RA. Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. Chest. 2005;128(3):1179-86.
Stoller JK, Brantly M. The challenge of detecting alpha-1 antitrypsin deficiency. COPD: J Chr Obstruct Pulm Dis. 2013;10(sup1):26-34.
Lieberman J, Winter B, Sastre A. Alpha1-antitrypsin Pi-types in 965 COPD patients. Chest. 1986;89(3):370-3.
Menga G, Acquier MF, Echazarreta AL, Sorroche PB, Lorenzon MV, Fernández ME, et al. Prevalence of alpha-1 antitrypsin deficiency in COPD patients in Argentina. The DAAT. AR Study. Arch Bronconeumol. 2020;56(9):571-7.
Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet (London, England). 2005;365(9478):2225-36.
Boulyjenkov V. α1-Antitrypsin deficiency: Memorandum from a WHO meeting. Bull. World Health Organ. 1997;75:397-415.
Rahaghi F, Ortega I, Rahaghi N, Oliveira E, Ramirez J, Smolley L, et al. Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results. COPD: J Chr Obstruct Pulm Dis. 2009;6(1):26-30.
Decramer M, Veslbo J, Bourbeau J, Celli B, Lopez Varela MV. Global initiative for chronic obstructive lung disease. Update 2014. Am J Respir Crit Care Med. 2012;186:975-81.
Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respirat Crit Care Medi. 1999;159(1):179-87.
Martinez-González C, Blanco I, Diego I, Bueno P, Miravitlles M. Estimated prevalence and number of PiMZ genotypes of Alpha-1 antitrypsin in seventy-four Countries Worldwide. Int J Chr Obstruct Pulm Dis. 2021:2617-30.
Strnad P, McElvaney NG, Lomas DA. Alpha1-antitrypsin deficiency. N En J Medi. 2020;382(15):1443-55.
Dahl M, Tybjærg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in α1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Annals Int Medi. 2002;136(4):270-9.
Greulich T, Vogelmeier CF. Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis. Therap Advan Respirat Dis. 2016;10(1):72-84.
Russo R, Zillmer LR, Nascimento OA, Manzano B, Ivanaga IT, Fritscher L, et al. Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil. J Brasil Pneumol. 2016;42(05):311-6.
Alí-Munive A, Leidy P, Proaños NJ, Pedrozo-Pupo J, Giraldo A, Cano D, et al. Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia. BMC Pulm Medi. 2023;23(1):156.
Barrecheguren M, Monteagudo M, Simonet P, Llor C, Rodriguez E, Ferrer J, et al. Diagnosis of alpha-1 antitrypsin deficiency: a population-based study. Int J Chr Obstruct Pulmon Dis. 201:999-1004.
Topic A, Stankovic M, Divac-Rankov A, Petrovic-Stanojevic N, Mitic-Milikic M, Nagorni-Obradovic L, et al. Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases. Genet Test Mole Biomark. 2012;16(11):1282-6.
Serapinus D, Nutautiene R, Pukinskaite R, Bartkeviciene D, Barkauskiene D, Sakalauskas R. Association of alpha-1 antitrypsin level and lung function in patients with chronic obstructive pulmonary disease. Serbi Arch Medi. 2017;145(11-12):580-3.
Downloads
Published
How to Cite
Issue
Section
